StemCells Inc

       
$0.52
Change

0.05

  

10.92%

10 Days Price Trend
September 4, 2015Advice  Valuation
Highest PriceSeptember 4, 20150.52
Lowest PricAugust 7, 20150.38

StemCells Market Sensitivity

As returns on market increase, StemCells returns are expected to increase less than the market. However during bear market, the loss on holding StemCells will be expected to be smaller as well.

StemCells Inc Market Cap Over Time

SymbolSTEM
NameStemCells Inc
InstrumentUSA Stock
SectorHealthcare
IndustryBiotechnology
BenchmarkNYSE
Websitehttp://www.stemcellsinc.com
Contact Number510 456 4000
Analyst ConsensusStrong Buy 3 Opinions
Risk-adjusted AdviceHold Under Valued
CurrencyUSD - US Dollar
ExchangeNasdaq Capital Markets
DescriptionStemCells Inc. a biopharmaceutical company researches develops and commercializes cellbased therapeutics and related technologies for stem cellbased research and drug discovery and development. more

Key Fundamentals

StemCells Agains Markets

 thisGreen STEM STEM agains markets  10.92 % Macroaxis: change 10.92 Moved Up  
 
 United States NYSE   0.36 % Macroaxis: 0.36 Moved Up  
 
 United States SP 500   0.12 % Macroaxis: 0.12 Moved Up  
 
 United States Russel   0.08 % Macroaxis: 0.0763 Moved Down  
 
 United States Nasdaq   0.35 % Macroaxis: 0.35 Moved Down  
 
Compare to Competition   Compare Correlations

StemCells Leadership

Martin McGlynn CEO, Director, Member of Strategic Transactions Committee, CEO of Stemcells California Inc and President of Stemcells California Inc
John Schwartz Independent Chairman of the Board, Ph.D
More Executives

StemCells Diversification Suggestion

Use StemCells to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of StemCells to be traded at $0.65 in 30 days

StemCells Daily Price Distribution

The median price of StemCells for the period between Wed, Aug 5, 2015 and Fri, Sep 4, 2015 is 0.41 with a coefficient of variation of 8.3. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 0.42, and mean deviation of 0.03. The Stock received some media coverage during the period.

StemCells Summary

StemCells Inc [STEM] is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 69 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 47.37 M. StemCells Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 108.52 M outstanding shares of which 2.2 M shares are at this time shorted by private and institutional investors with about 1.8 trading days to cover.

StemCells Inc Accumulated Other Comprehensive Income Over Time

30 Days Rating

 
Past Market
Performance (0 to 100)
14
Chance of
90

StemCells Alerts

StemCells Inc appears to be very risky and stock price may revert if volatility continues
StemCells Inc has some characteristics of a very speculative penny stock
StemCells Inc has high likelihood to experience some financial distress in the next 2 years
The company reported previous year revenue of 797.73 K. Net Loss for the year was (30.4 M) with profit before overhead, payroll, taxes, and interest of 1.01 M.
STEMCELLS INC currently holds about 29.93 M in cash with (29.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Roughly 24.0% of the company outstanding shares are owned by corporate insiders

StemCells Upcoming Events

Upcoming Quarterly ReportNovember 4, 2015
Next Earnings ReportMarch 21, 2016

StemCells Earnings Estimates

EPSEstimate Date
Quarterly Estimate-0.1November 4, 2015
StemCells Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
StemCells Earnings Estimate  

StemCells Analyst Recommendations

Target PriceConsensus AdviceNumber of Analysts
2.387Strong Buy4
StemCells Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
StemCells Analyst Recommendations  

StemCells Research Report

Get StemCells research report. Reports are available in pdf format and contain fundamental information about the equity. Click Generate StemCells report to view

StemCells Pair Trading Analysis

Correlation analysis and pair trading evaluation for StemCells and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Macroaxis investing theme could easily outperform a given market if properly optimized
Explore Investing Ideas  

StemCells Directors

Irving Weissman Director
Eric Bjerkholt Independent Director
R Greer Independent Director
Ricardo Levy Independent Director
Alan Trounson Director

StemCells Fundamentals Correlation

StemCells vs Competition

StemCells September 4, 2015 Opportunity Range